1. 1) Kuo CF, Grainge MJ, Zhang W, Doherty M. Global epidemiology of gout: prevalence, incidence and risk factors. Nat. Rev. Rheumatol., 11, 649–662 (2015).
2. 2) Liu R, Han C, Wu D, Xia X, Gu J, Guan H, Shan Z, Teng W. Prevalence of hyperuricemia and gout in Mainland China from 2000 to 2014: a systematic review and meta-analysis. Biomed. Res. Int., 2015, 762820 (2015).
3. 3) Clarson LE, Hider SL, Belcher J, Heneghan C, Roddy E, Mallen CD. Increased risk of vascular disease associated with gout: a retrospective, matched cohort study in the U.K. clinical practice research datalink. Ann. Rheum. Dis., 74, 642–647 (2015).
4. 4) Li Q, Li X, Kwong JS, Chen H, Sun X, Tian H, Li S. Diagnosis and treatment for hyperuricaemia and gout: a protocol for a systematic review of clinical practice guidelines and consensus statements. BMJ Open, 7, e014928 (2017).
5. 5) Taniguchi Y, Hayashi T, Tsumura K, Endo G, Fujii S, Okada K. Serum uric acid and the risk for hypertension and type 2 diabetes in Japanese men: the Osaka health survey. J. Hypertens., 19, 1209–1215 (2001).